Copyright Reports & Markets. All rights reserved.

Global Oocyte/Embryo Vitrification Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oocyte/Embryo Vitrification Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Open System
    • 1.3.3 Closed System
  • 1.4 Market Analysis by Structure
    • 1.4.1 Overview: Global Oocyte/Embryo Vitrification Device Consumption Value by Structure: 2021 Versus 2025 Versus 2032
    • 1.4.2 Film/Strip
    • 1.4.3 Straw
    • 1.4.4 Loop
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Oocyte/Embryo Vitrification Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Hospital
    • 1.5.3 Biotechnology Company
    • 1.5.4 Research Laboratory
  • 1.6 Global Oocyte/Embryo Vitrification Device Market Size & Forecast
    • 1.6.1 Global Oocyte/Embryo Vitrification Device Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Oocyte/Embryo Vitrification Device Sales Quantity (2021-2032)
    • 1.6.3 Global Oocyte/Embryo Vitrification Device Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Kitazato Corporation
    • 2.1.1 Kitazato Corporation Details
    • 2.1.2 Kitazato Corporation Major Business
    • 2.1.3 Kitazato Corporation Oocyte/Embryo Vitrification Device Product and Services
    • 2.1.4 Kitazato Corporation Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Kitazato Corporation Recent Developments/Updates
  • 2.2 Vitrolife
    • 2.2.1 Vitrolife Details
    • 2.2.2 Vitrolife Major Business
    • 2.2.3 Vitrolife Oocyte/Embryo Vitrification Device Product and Services
    • 2.2.4 Vitrolife Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Vitrolife Recent Developments/Updates
  • 2.3 CooperSurgical
    • 2.3.1 CooperSurgical Details
    • 2.3.2 CooperSurgical Major Business
    • 2.3.3 CooperSurgical Oocyte/Embryo Vitrification Device Product and Services
    • 2.3.4 CooperSurgical Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 CooperSurgical Recent Developments/Updates
  • 2.4 Reprolife
    • 2.4.1 Reprolife Details
    • 2.4.2 Reprolife Major Business
    • 2.4.3 Reprolife Oocyte/Embryo Vitrification Device Product and Services
    • 2.4.4 Reprolife Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Reprolife Recent Developments/Updates
  • 2.5 Biotech
    • 2.5.1 Biotech Details
    • 2.5.2 Biotech Major Business
    • 2.5.3 Biotech Oocyte/Embryo Vitrification Device Product and Services
    • 2.5.4 Biotech Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Biotech Recent Developments/Updates
  • 2.6 Cryo Bio System
    • 2.6.1 Cryo Bio System Details
    • 2.6.2 Cryo Bio System Major Business
    • 2.6.3 Cryo Bio System Oocyte/Embryo Vitrification Device Product and Services
    • 2.6.4 Cryo Bio System Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cryo Bio System Recent Developments/Updates
  • 2.7 VITROMED
    • 2.7.1 VITROMED Details
    • 2.7.2 VITROMED Major Business
    • 2.7.3 VITROMED Oocyte/Embryo Vitrification Device Product and Services
    • 2.7.4 VITROMED Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 VITROMED Recent Developments/Updates
  • 2.8 VitaVitro Biotech
    • 2.8.1 VitaVitro Biotech Details
    • 2.8.2 VitaVitro Biotech Major Business
    • 2.8.3 VitaVitro Biotech Oocyte/Embryo Vitrification Device Product and Services
    • 2.8.4 VitaVitro Biotech Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 VitaVitro Biotech Recent Developments/Updates
  • 2.9 Shanghai Horizon Medical
    • 2.9.1 Shanghai Horizon Medical Details
    • 2.9.2 Shanghai Horizon Medical Major Business
    • 2.9.3 Shanghai Horizon Medical Oocyte/Embryo Vitrification Device Product and Services
    • 2.9.4 Shanghai Horizon Medical Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shanghai Horizon Medical Recent Developments/Updates
  • 2.10 Guangzhou Zooming Instrument
    • 2.10.1 Guangzhou Zooming Instrument Details
    • 2.10.2 Guangzhou Zooming Instrument Major Business
    • 2.10.3 Guangzhou Zooming Instrument Oocyte/Embryo Vitrification Device Product and Services
    • 2.10.4 Guangzhou Zooming Instrument Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Guangzhou Zooming Instrument Recent Developments/Updates
  • 2.11 Basecare Medical
    • 2.11.1 Basecare Medical Details
    • 2.11.2 Basecare Medical Major Business
    • 2.11.3 Basecare Medical Oocyte/Embryo Vitrification Device Product and Services
    • 2.11.4 Basecare Medical Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Basecare Medical Recent Developments/Updates
  • 2.12 Guangzhou Huayuexing Medical Technology
    • 2.12.1 Guangzhou Huayuexing Medical Technology Details
    • 2.12.2 Guangzhou Huayuexing Medical Technology Major Business
    • 2.12.3 Guangzhou Huayuexing Medical Technology Oocyte/Embryo Vitrification Device Product and Services
    • 2.12.4 Guangzhou Huayuexing Medical Technology Oocyte/Embryo Vitrification Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Guangzhou Huayuexing Medical Technology Recent Developments/Updates

3 Competitive Environment: Oocyte/Embryo Vitrification Device by Manufacturer

  • 3.1 Global Oocyte/Embryo Vitrification Device Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Oocyte/Embryo Vitrification Device Revenue by Manufacturer (2021-2026)
  • 3.3 Global Oocyte/Embryo Vitrification Device Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Oocyte/Embryo Vitrification Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Oocyte/Embryo Vitrification Device Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Oocyte/Embryo Vitrification Device Manufacturer Market Share in 2025
  • 3.5 Oocyte/Embryo Vitrification Device Market: Overall Company Footprint Analysis
    • 3.5.1 Oocyte/Embryo Vitrification Device Market: Region Footprint
    • 3.5.2 Oocyte/Embryo Vitrification Device Market: Company Product Type Footprint
    • 3.5.3 Oocyte/Embryo Vitrification Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oocyte/Embryo Vitrification Device Market Size by Region
    • 4.1.1 Global Oocyte/Embryo Vitrification Device Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Oocyte/Embryo Vitrification Device Consumption Value by Region (2021-2032)
    • 4.1.3 Global Oocyte/Embryo Vitrification Device Average Price by Region (2021-2032)
  • 4.2 North America Oocyte/Embryo Vitrification Device Consumption Value (2021-2032)
  • 4.3 Europe Oocyte/Embryo Vitrification Device Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Oocyte/Embryo Vitrification Device Consumption Value (2021-2032)
  • 4.5 South America Oocyte/Embryo Vitrification Device Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Oocyte/Embryo Vitrification Device Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Oocyte/Embryo Vitrification Device Sales Quantity by Type (2021-2032)
  • 5.2 Global Oocyte/Embryo Vitrification Device Consumption Value by Type (2021-2032)
  • 5.3 Global Oocyte/Embryo Vitrification Device Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Oocyte/Embryo Vitrification Device Sales Quantity by Application (2021-2032)
  • 6.2 Global Oocyte/Embryo Vitrification Device Consumption Value by Application (2021-2032)
  • 6.3 Global Oocyte/Embryo Vitrification Device Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Oocyte/Embryo Vitrification Device Sales Quantity by Type (2021-2032)
  • 7.2 North America Oocyte/Embryo Vitrification Device Sales Quantity by Application (2021-2032)
  • 7.3 North America Oocyte/Embryo Vitrification Device Market Size by Country
    • 7.3.1 North America Oocyte/Embryo Vitrification Device Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Oocyte/Embryo Vitrification Device Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Oocyte/Embryo Vitrification Device Sales Quantity by Type (2021-2032)
  • 8.2 Europe Oocyte/Embryo Vitrification Device Sales Quantity by Application (2021-2032)
  • 8.3 Europe Oocyte/Embryo Vitrification Device Market Size by Country
    • 8.3.1 Europe Oocyte/Embryo Vitrification Device Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Oocyte/Embryo Vitrification Device Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oocyte/Embryo Vitrification Device Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Oocyte/Embryo Vitrification Device Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Oocyte/Embryo Vitrification Device Market Size by Region
    • 9.3.1 Asia-Pacific Oocyte/Embryo Vitrification Device Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Oocyte/Embryo Vitrification Device Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Oocyte/Embryo Vitrification Device Sales Quantity by Type (2021-2032)
  • 10.2 South America Oocyte/Embryo Vitrification Device Sales Quantity by Application (2021-2032)
  • 10.3 South America Oocyte/Embryo Vitrification Device Market Size by Country
    • 10.3.1 South America Oocyte/Embryo Vitrification Device Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Oocyte/Embryo Vitrification Device Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oocyte/Embryo Vitrification Device Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Oocyte/Embryo Vitrification Device Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Oocyte/Embryo Vitrification Device Market Size by Country
    • 11.3.1 Middle East & Africa Oocyte/Embryo Vitrification Device Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Oocyte/Embryo Vitrification Device Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Oocyte/Embryo Vitrification Device Market Drivers
  • 12.2 Oocyte/Embryo Vitrification Device Market Restraints
  • 12.3 Oocyte/Embryo Vitrification Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oocyte/Embryo Vitrification Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oocyte/Embryo Vitrification Device
  • 13.3 Oocyte/Embryo Vitrification Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oocyte/Embryo Vitrification Device Typical Distributors
  • 14.3 Oocyte/Embryo Vitrification Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oocyte/Embryo Vitrification Device market size was valued at US$ 90.55 million in 2025 and is forecast to a readjusted size of US$ 146 million by 2032 with a CAGR of 7.1% during review period.
    Oocyte/embryo vitrification device is a specialized ART consumable used to load, transfer and preserve oocytes or embryos under ultra-rapid cooling conditions, typically in combination with vitrification media for cryogenic storage.
    In 2025, global production of Oocyte/Embryo Vitrification Devices reached 6.8 million units, with an average selling price of US$13 per unit and total production capacity of approximately 9.0 million units. The industry gross margin was about 35%–55%. In terms of cost structure, direct materials accounted for around 58%, manufacturing overhead for around 32%, and labor for around 10%. The upstream supply chain includes medical-grade polymer materials, micro-carriers/films, capillaries, carrier rod handles, and related components; downstream users include assisted reproductive centers, IVF laboratories, hospital reproductive medicine centers, oocyte banks, embryo banks, fertility preservation institutions, egg/embryo donation programs, and third-party assisted reproductive service providers.
    The global market for oocyte and embryo vitrification devices expands steadily alongside rising assisted reproduction cycles. Health authority data from many countries show that delayed childbearing and increasing infertility are pushing demand for IVF treatment, directly driving consumption of specialized carriers. As vitrification has fully replaced slow freezing due to superior survival rates, carriers must deliver ultra-fast heat transfer, secure ultra-small cryoprotectant volumes, and guarantee sterility. According to annual reports and product registrations of leading manufacturers, innovation concentrates on fully closed systems that eliminate cross-contamination risk from direct liquid nitrogen contact, simplify handling to shorten embryo exposure, and improve compatibility with automated vitrification workflows. Regulatory clearances like CE marking and FDA approval strongly shape buying patterns, as closed carriers are preferred by large fertility clinics to meet infection control and quality standards. Asia-based production bases form the core of global supply through scale and cost advantages, while North America and Europe remain high-value consumption markets. With public insurance coverage for fertility treatments expanding in some regions, centralized procurement by public hospitals imposes greater cost pressures, yet does not weaken the emphasis on safety and traceability. Differentiation revolves around biocompatible materials, unique barcode traceability, and integrated cold chain logistics. Public disclosures indicate that suppliers holding full certifications and cold chain capabilities are consolidating channel strength, concentrating market resources toward leading players and steadily raising barriers for smaller firms lacking credentials and brand trust.
    This report is a detailed and comprehensive analysis for global Oocyte/Embryo Vitrification Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oocyte/Embryo Vitrification Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oocyte/Embryo Vitrification Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oocyte/Embryo Vitrification Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oocyte/Embryo Vitrification Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oocyte/Embryo Vitrification Device
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oocyte/Embryo Vitrification Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kitazato Corporation, Vitrolife, CooperSurgical, Reprolife, Biotech, Cryo Bio System, VITROMED, VitaVitro Biotech, Shanghai Horizon Medical, Guangzhou Zooming Instrument, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Oocyte/Embryo Vitrification Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Open System
    Closed System
    Market segment by Structure
    Film/Strip
    Straw
    Loop
    Market segment by Application
    Hospital
    Biotechnology Company
    Research Laboratory
    Major players covered
    Kitazato Corporation
    Vitrolife
    CooperSurgical
    Reprolife
    Biotech
    Cryo Bio System
    VITROMED
    VitaVitro Biotech
    Shanghai Horizon Medical
    Guangzhou Zooming Instrument
    Basecare Medical
    Guangzhou Huayuexing Medical Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Oocyte/Embryo Vitrification Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Oocyte/Embryo Vitrification Device, with price, sales quantity, revenue, and global market share of Oocyte/Embryo Vitrification Device from 2021 to 2026.
    Chapter 3, the Oocyte/Embryo Vitrification Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Oocyte/Embryo Vitrification Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oocyte/Embryo Vitrification Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Oocyte/Embryo Vitrification Device.
    Chapter 14 and 15, to describe Oocyte/Embryo Vitrification Device sales channel, distributors, customers, research findings and conclusion.

    Buy now